Abstract
Purpose
Our previous study reported that carcinoembryonic antigen (CEA) levels in peritoneal fluid were significantly correlated with the prevalence of peritoneal carcinomatosis (PC) in colorectal cancer (CRC). The purpose of this study was a long-term follow up of the author’s previous study, as well as the identification of correlations with the known risk factors of PC and the comparison of the predictive power of PC in CRC.
Methods
A total of 495 patients without PC who underwent CRC operations at St. Mary’s Hospital, The Catholic University of Korea, from January 2006 to November 2014 were included in this study. Tumor markers of peritoneal fluid sampled at the beginning of each operation were prospectively analyzed and compared with the known risk factors for PC in CRC.
Results
Multivariate analysis of PC revealed that T4 cancer (OR 5.143, 95% CI 1.400–18.897, p = 0.014), T3 mucinous cancer (OR 17.480, 95% CI 1.577–193.714, p = 0.020), obstructed tumors (OR 6.030, 95% CI 1.627–22.343, p = 0.007), and peritoneal fluid CEA above 5 ng/dl (OR 4.073, 95% CI 1.315–12.615, p = 0.015) were significant risk factors. T4 cancer, obstructed tumors, and peritoneal fluid CEA above 5 ng/dl showed correlations with cancer-free survival. Generally, higher CEA levels in peritoneal fluid were correlated with previously known risk factors for PC in CRC.
Conclusion
Peritoneal fluid CEA has predictive value for PC and prognostic value in CRC. Therefore, we recommend routinely performing ascites CEA analysis in colorectal cancer surgery.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00384-019-03448-2/MediaObjects/384_2019_3448_Fig1_HTML.png)
Similar content being viewed by others
References
Birgisson H, Talbäck M, Gunnarsson U, Påhlman L, Glimelius B (2005) Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol 31:845–853. https://doi.org/10.1016/j.ejso.2005.05.002
Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1:1479–1482. https://doi.org/10.1016/s0140-6736(86)91510-2
Quirke P, Sebag-Montefiore D, Steele R, Khanna S, Monson J, Holliday A, Thompson L, Griffiths G, Stephens R (2006) Local recurrence after rectal cancer resection is strongly related to the plane of surgical dissection and is further reduced by pre-operative short course radiotherapy. Preliminary results of the Medical Research Council (MRC) CR07 trial. J Clin Oncol 24:3512. https://doi.org/10.1200/jco.2006.24.18_suppl.3512
Jayne DG, Fook S, Loi C, Seow-Choen F (2002) Peritoneal carcinomatosis from colorectal cancer. Br J Surg 89:1545–1550. https://doi.org/10.1046/j.1365-2168.2002.02274.x
Lemmens VE, Klaver YL, Verwaal VJ, Rutten HJ, Coebergh JW, de Hingh IH (2011) Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study. Int J Cancer 128:2717–2725. https://doi.org/10.1002/ijc.25596
Segelman J, Granath F, Holm T, Machado M, Mahteme H, Martling A (2012) Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg 99:699–705. https://doi.org/10.1002/bjs.8679
Hase K, Ueno H, Kuranaga N, Utsunomiya K, Kanabe S, Mochizuki H (1998) Intraperitoneal exfoliated cancer cells in patients with colorectal cancer. Dis Colon Rectum 41:1134–1140. https://doi.org/10.1007/bf02239435
Shen-Gunther J, Mannel RS (2002) Ascites as a predictor of ovarian malignancy. Gynecol Oncol 87:77–83. https://doi.org/10.1006/gyno.2002.6800
Yamamoto S, Akasu T, Fujita S, Moriya Y (2003) Long-term prognostic value of conventional peritoneal cytology after curative resection for colorectal carcinoma. Jpn J Clin Oncol 33:33–37. https://doi.org/10.1093/jjco/hyg007
Sugarbaker PH (2014) Colorectal cancer: prevention and management of metastatic disease. Biomed Res Int 2014:782890. https://doi.org/10.1155/2014/782890
Wilkiemeyer MB, Bieligk SC, Ashfaq R, Jones DB, Rege RV, Fleming JB (2004) Laparoscopy alone is superior to peritoneal cytology in staging gastric and esophageal carcinoma. Surg Endosc 18:852–856. https://doi.org/10.1007/s00464-003-8828-z
Fanning J, Markuly SN, Hindman TL, Galle PC, McRae MA, Visnesky PM, Hilgers RD (1996) False positive malignant peritoneal cytology and psammoma bodies in benign gynecologic disease. J Reprod Med 41:504–508
Sloots CE, de Brauw LM, Bot FJ, Greve JW (1999) False-positive cytology in diagnostic laparoscopy due to ectopic pancreas. Dig Surg 16:434–436. https://doi.org/10.1159/000018762
Cunliffe WJ, Sugarbaker PH (1989) Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy. Br J Surg 76:1082–1090. https://doi.org/10.1002/bjs.1800761030
Lee IK, Kim DH, Gorden DL, Lee YS, Sung NY, Park GS, Kim HJ, Kang WK, Park JK, Ahn CH, Kim JG, Jeon HM, Oh ST (2009) Prognostic value of CEA and CA 19-9 tumor markers combined with cytology from peritoneal fluid in colorectal cancer. Ann Surg Oncol 16:861–870. https://doi.org/10.1245/s10434-008-0294-3
Jayne DG (2003) The molecular biology of peritoneal carcinomatosis from gastrointestinal cancer. Ann Acad Med Singap 32:219–225
Yamamoto M, Baba H, Kakeji Y, Endo K, Ikeda Y, Toh Y, Kohnoe S, Okamura T, Maehara Y (2004) Prognostic significance of tumor markers in peritoneal lavage in advanced gastric cancer. Oncology 67:19–26. https://doi.org/10.1159/000080281
Fiegl M, Haun M, Massoner A, Krugmann J, Müller-Holzner E, Hack R, Hilbe W, Marth C, Duba HC, Gastl G, Grünewald K (2004) Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusions. J Clin Oncol 22:474–483. https://doi.org/10.1200/JCO.2004.06.063
Nagy JA, Masse EM, Herzberg KT, Meyers MS, Yeo KT, Yeo TK, Sioussat TM, Dvorak HF (1995) Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Cancer Res 55:360–368
Lee IK, Yi JM, Lee YS, Kim HJ, Park JK, Oh ST, Kim JG, Jeon HM, Chang SK (2006) The significance of peritoneal effusion in colorectal cancer. J Korean Soc Coloproctol 22:308–313
Vogel P, Rüschoff J, Kümmel S, Zirngibl H, Hofstädter F, Hohenberger W, Jauch KW (2000) Prognostic value of microscopic peritoneal dissemination: comparison between colon and gastric cancer. Dis Colon Rectum 43:92–100. https://doi.org/10.1007/bf02237250
Kanellos I, Demetriades H, Zintzaras E, Mandrali A, Mantzoros I, Betsis D (2003) Incidence and prognostic value of positive peritoneal cytology in colorectal cancer. Dis Colon Rectum 46:535–539. https://doi.org/10.1097/01.DCR.0000054701.01863.2A
Zirngibl H, Husemann B, Hermanek P (1990) Intraoperative spillage of tumor cells in surgery for rectal cancer. Dis Colon Rectum 33:610–614. https://doi.org/10.1007/bf02052218
Ranbarger KR, Johnston WD, Chang JC (1982) Prognostic significance of surgical perforation of the rectum during abdominoperineal resection for rectal carcinoma. Am J Surg 143:186–188. https://doi.org/10.1016/0002-9610(82)90063-0
Chen HS, Sheen-Chen SM (2000) Obstruction and perforation in colorectal adenocarcinoma: an analysis of prognosis and current trends. Surgery 127:370–376. https://doi.org/10.1067/msy.2000.104674
Steinberg SM, Barkin JS, Kaplan RS, Stablein DM (1986) Prognostic indicators of colon tumors. The Gastrointestinal Tumor Study Group experience. Cancer 57:1866–1870. https://doi.org/10.1002/1097-0142(19860501)57:9<1866::aid-cncr2820570928>3.0.co;2-t
Lehnert T, Buhl K, Dueck M, Hinz U, Herfarth C (2000) Two-stage radical gastrectomy for perforated gastric cancer. Eur J Surg Oncol 26:780–784. https://doi.org/10.1053/ejso.2000.1003
Elias D, Blot F, El Otmany A, Antoun S, Lasser P, Boige V, Rougier P, Ducreux M (2001) Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92:71–76. https://doi.org/10.1002/1097-0142(20010701)92:1<71::aid-cncr1293>3.0.co;2-9
Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, Zoetmulder FA (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737–3743. https://doi.org/10.1200/JCO.2003.04.187
Sugarbaker PH (1995) Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer. World J Surg 19:235–240. https://doi.org/10.1007/bf00308632
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict(s) of interest.
Ethical approval
All procedures performed in this study were in accordance with the ethical standards of the Institutional Review Board at the College of Medicine, The Catholic University of Korea, Republic of Korea (IRB 2018-3483-0001), and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kim, B.C., Bae, J.H., Park, S.M. et al. Is ascites CEA a risk factor for peritoneal carcinomatosis in colorectal cancer?: a long-term follow-up study. Int J Colorectal Dis 35, 147–155 (2020). https://doi.org/10.1007/s00384-019-03448-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-019-03448-2